Arch Therapeutics, Inc. Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arch Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arch Therapeutics, Inc. for July 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.43 | 110,000 | 46,750 | 110,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 110,000 | 0 | 370,000 | 260 K to 370 K (+42.31 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.43 | 360,000 | 153,000 | 360,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Grant | A | 0.00 | 360,000 | 0 | 3,559,076 | 3.2 M to 3.6 M (+11.25 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.43 | 275,000 | 116,875 | 275,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Grant | A | 0.00 | 275,000 | 0 | 878,000 | 603 K to 878 K (+45.61 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.43 | 200,000 | 85,000 | 200,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.43 | 220,000 | 93,500 | 220,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 220,000 | 0 | 8,517,373 | 8.3 M to 8.5 M (+2.65 %) |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | M | 0.37 | 30,000 | 11,100 | 0 | |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | M | 0.37 | 30,000 | 11,100 | 260,000 | 230 K to 260 K (+13.04 %) |